New analysis from Frost & Sullivan indicates that so-called “smart pills” may be the next big thing in health tech.
With each passing year, the increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills.
Researchers at Frost & Sullivan find a “clear trend” towards minimally invasive and remote controlled devices for diagnosis and therapy.
Smart pills are widely used for gastrointestinal imaging too, replacing invasive endoscopes. Advancements in enabling technologies, such as wireless communications, remote patient monitoring, and miniaturization, will widen smart pill applications.
“The smart pills industry is likely to experience a burst of new products in the next five to seven years, offering tremendous potential for collaboration between the industry and academia,” observes Technical Insights Research Analyst Bhargav Rajan. “While overarching product designs developed by the industry can lead to breakthrough products such as capsule endoscopes, it is by leveraging ideas from basic and applied sciences at universities and research centers that product differentiation and value enhancement can be achieved.”